Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment
BioPharma
Stay updated with breaking news from Function Oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Function Oncology goes beyond next-generation sequencing with a CRISPR-based technology that identifies targets for a patient’s cancer regardless of whether or not they are mutated. Now out of stealth, the company will present data validating its approach during the American Association for Cancer Research annual meeting.
Function Oncology is committed to advancing targeted cancer treatments by measuring gene function at the level of individual patients.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!